• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《视觉 2020:我们在哪里?》

Vision 2020: where are we?

机构信息

Glaucoma Service, Cambridge University Hospital.

Vision & Eye Research Institute, School of Medicine, Anglia Ruskin University, Cambridge, UK.

出版信息

Curr Opin Ophthalmol. 2020 Mar;31(2):81-84. doi: 10.1097/ICU.0000000000000647.

DOI:10.1097/ICU.0000000000000647
PMID:31904597
Abstract

PURPOSE OF REVIEW

To describe the VISION 2020: The Right to Sight, global initiative for the elimination of avoidable blindness, the contribution of glaucoma to the magnitude of global blindness and priorities going forward.

RECENT FINDINGS

Although the target of the World Health Organization's Global Action Plan (2014-2019) has not been met in terms of 25% reduction in avoidable blindness, there is evidence that the contribution of glaucoma to blindness and vision impairment is reducing. Yet this focus on a threshold of visual acuity by which to measure prevalence underestimates the true burden of glaucoma. Recent population-based studies demonstrate the scale of the unmet need.

SUMMARY

Scaling up of integrated people-centered eye care, by embedding glaucoma detection and care pathways in health systems with a strong focus on primary healthcare, is necessary. Solutions include reinforcing existing pathways while emphasizing high-quality glaucoma care, in addition to novel solutions such as self-testing, digital portable technology, artificial intelligence, and multilevel care pathways that extend to the most underserved parts of the global community.

摘要

目的综述

描述 VISION 2020:看见的权利,这一消除可避免盲目的全球倡议,青光眼对全球盲症严重程度的影响,以及未来的优先事项。

最新发现

尽管世界卫生组织全球行动计划(2014-2019 年)在降低 25%可避免盲症方面的目标尚未实现,但有证据表明,青光眼对盲症和视力损害的影响正在减少。然而,这种关注视力敏锐度的阈值来衡量患病率,低估了青光眼的真正负担。最近的基于人群的研究表明了未满足需求的规模。

总结

通过将青光眼检测和护理途径嵌入以初级保健为重点的综合以人为本的眼科保健系统,来扩大服务范围是必要的。解决方案包括加强现有途径,同时强调高质量的青光眼护理,以及新的解决方案,如自我检测、数字便携技术、人工智能和多层次的护理途径,这些途径延伸到全球社区最服务不足的地区。

相似文献

1
Vision 2020: where are we?《视觉 2020:我们在哪里?》
Curr Opin Ophthalmol. 2020 Mar;31(2):81-84. doi: 10.1097/ICU.0000000000000647.
2
Vision 2020 - the right to sight.“视觉2020”——享有看见的权利。
Ann Trop Med Parasitol. 2008 Sep;102 Suppl 1:3-5. doi: 10.1179/136485908X337409.
3
[Tropical ophthalmology--prevention and therapy"Vision 2020--the right to sight"].[热带眼科——预防与治疗《2020 视觉——享有看见的权利》]
Ophthalmologe. 2004 Jul;101(7):741-63; quiz 764-5. doi: 10.1007/s00347-004-1039-8. Epub 2004 Jun 16.
4
International Vision Care: Issues and Approaches.国际视野保健:问题与方法。
Annu Rev Vis Sci. 2017 Sep 15;3:53-68. doi: 10.1146/annurev-vision-102016-061407.
5
VISION 2020: the right to sight. A global initiative for the elimination of avoidable blindness.“视觉2020:享有看见的权利”。一项消除可避免盲症的全球倡议。
Optometry. 2001 Oct;72(10):619-22.
6
Thirty Year Projected Magnitude (to 2050) of Near and Distance Vision Impairment and the Economic Impact if Existing Solutions are Implemented Globally.全球实施现有解决方案对近距和远距离视力损伤的三十年预测规模(到 2050 年)及其经济影响。
Ophthalmic Epidemiol. 2020 Apr;27(2):115-120. doi: 10.1080/09286586.2019.1700532. Epub 2019 Dec 6.
7
Magnitude and causes of blindness and low vision in Anambra State of Nigeria (results of 1992 point prevalence survey).尼日利亚阿南布拉州失明和视力低下的程度及原因(1992年现患率调查结果)
Public Health. 1997 Sep;111(5):305-9.
8
Prevalence of blindness and low vision in north central, Nigeria.尼日利亚中北部失明和视力低下的患病率。
West Afr J Med. 2008 Oct;27(4):238-44.
9
Looking forward to 20/20: a focus on the epidemiology of eye diseases.展望20/20:聚焦眼病流行病学
Epidemiol Rev. 2000;22(1):64-70. doi: 10.1093/oxfordjournals.epirev.a018025.
10
Epidemiologic aspects of global blindness prevention.全球失明预防的流行病学方面。
Curr Opin Ophthalmol. 1992 Dec;3(6):824-34. doi: 10.1097/00055735-199212000-00016.

引用本文的文献

1
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年因年龄相关性黄斑变性导致的视力损害全球负担,以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3.
2
Global prevalence and years lived with disability (YLDs) of cataract in 204 countries and territories: findings from the Global Burden of Disease Study 2021.204个国家和地区白内障的全球患病率及伤残调整生命年(YLDs):全球疾病负担研究2021的结果
Eye (Lond). 2025 Mar 11. doi: 10.1038/s41433-025-03743-z.
3
Global, regional, and national burden of age-related macular degeneration, 1990-2019: an age-period-cohort analysis based on the Global Burden of Disease 2019 Study.
全球、区域和国家与年龄相关的黄斑变性负担,1990-2019 年:基于 2019 年全球疾病负担研究的年龄-时期-队列分析。
Front Public Health. 2024 Oct 22;12:1486168. doi: 10.3389/fpubh.2024.1486168. eCollection 2024.
4
Vision impairment and blindness in individuals aged 60 years and older in Latin America and the Caribbean.拉丁美洲和加勒比地区60岁及以上人群的视力障碍和失明情况。
Rev Panam Salud Publica. 2024 Oct 7;48:e101. doi: 10.26633/RPSP.2024.101. eCollection 2024.
5
Changing Trends in the Global Burden of Cataract Over the Past 30 Years: Retrospective Data Analysis of the Global Burden of Disease Study 2019.过去 30 年全球白内障负担的变化趋势:2019 年全球疾病负担研究的回顾性数据分析。
JMIR Public Health Surveill. 2023 Dec 5;9:e47349. doi: 10.2196/47349.
6
The burden of vision loss due to cataract in China: findings from the Global Burden of Disease Study 2019.中国因白内障导致的视力丧失负担:来自 2019 年全球疾病负担研究的发现。
Eye (Lond). 2024 Apr;38(5):885-892. doi: 10.1038/s41433-023-02798-0. Epub 2023 Oct 18.
7
Clinical Evaluation of MyoCare in Europe (CEME): study protocol for a prospective, multicenter, randomized, double-blinded, and controlled clinical trial.MyoCare 在欧洲的临床评估(CEME):一项前瞻性、多中心、随机、双盲、对照临床试验的研究方案。
Trials. 2023 Oct 17;24(1):674. doi: 10.1186/s13063-023-07696-0.
8
Trends and disparities in disease burden of age-related macular degeneration from 1990 to 2019: Results from the global burden of disease study 2019.1990 年至 2019 年与年龄相关的黄斑变性疾病负担的趋势和差异:2019 年全球疾病负担研究的结果。
Front Public Health. 2023 Apr 17;11:1138428. doi: 10.3389/fpubh.2023.1138428. eCollection 2023.
9
Time trends and heterogeneity in the disease burden of visual impairment due to cataract, 1990-2019: A global analysis.1990 年至 2019 年因白内障导致的视力障碍疾病负担的时间趋势和异质性:全球分析。
Front Public Health. 2023 Apr 3;11:1140533. doi: 10.3389/fpubh.2023.1140533. eCollection 2023.
10
Knowledge, Awareness, and Perception of Common Eye Diseases and Eye Donation Among People Seeking Healthcare in a Tertiary Hospital in Telangana, South India.印度南部特伦甘纳邦一家三级医院中寻求医疗服务的人群对常见眼病和眼捐赠的知晓、认识与认知情况。
Cureus. 2022 Nov 12;14(11):e31412. doi: 10.7759/cureus.31412. eCollection 2022 Nov.